Testing effectiveness (Phase 2)Ended earlyNCT00316433What this trial is testingOxaliplatin/CPT-11 for Extensive Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer Swedish Medical Center 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06306560What this trial is testingAdebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.Who this might be right forExtensive-stage Small-cell Lung Cancer Harbin Medical University 40
Not applicableLooking for participantsNCT07510724What this trial is testingReal-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor TislelizumabWho this might be right forSmall Cell Lung Cancer (SCLC)Non-Small Cell Lung Cancer (NSCLC)Lung Cancer (Diagnosis) Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 240
Large-scale testing (Phase 3)Study completedNCT00320359What this trial is testingTopotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung CancerWho this might be right forLung Cancer, Small Cell GlaxoSmithKline 700
Not applicableActive Not RecruitingNCT05683977What this trial is testingA French Real-life Study: EvaluatioN of durvALumab Utilization and Effectiveness for First Line Extensive Stage Small Cell Lung Cancer.Who this might be right forSmall Cell Lung Carcinoma AstraZeneca 254
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172412What this trial is testingOpen-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung CancerWho this might be right forExtensive Stage Lung Small Cell Cancer Tianjin Medical University Cancer Institute and Hospital 165
Not applicableNot Yet RecruitingNCT05066945What this trial is testingApplication of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC PatientsWho this might be right forSmall Cell Lung Cancer Extensive Stage Xiangya Hospital of Central South University 40
Early research (Phase 1)Study completedNCT00016237What this trial is testingInterleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous TreatmentWho this might be right forBladder CancerKidney CancerLung Cancer EMD Serono
Not applicableStudy completedNCT00433602What this trial is testingIncidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more European Organisation for Research and Treatment of Cancer - EORTC 64
Testing effectiveness (Phase 2)Study completedNCT00869752What this trial is testingMK-0646, Etoposide, and Cisplatin in Treating Patients With Extensive-Stage Small Cell Lung CancerWho this might be right forLung Cancer NCIC Clinical Trials Group 12
Testing effectiveness (Phase 2)Looking for participantsNCT07155174What this trial is testingEvaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer AbbVie 180
Testing effectiveness (Phase 2)Study completedNCT00193349What this trial is testingGleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung CancerWho this might be right forLung Cancer SCRI Development Innovations, LLC 60
Testing effectiveness (Phase 2)Study completedNCT00118235What this trial is testingCisplatin, Irinotecan, and Bevacizumab, in Treating Patients With Small Cell Lung CancerWho this might be right forExtensive Stage Small Cell Lung Cancer National Cancer Institute (NCI) 72
Large-scale testing (Phase 3)Study completedNCT00005590What this trial is testingLevofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forBrain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more Cancer Research Campaign Clinical Trials Centre
Large-scale testing (Phase 3)Looking for participantsNCT06646276What this trial is testingCompare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).Who this might be right forExtensive-Stage Small Cell Lung Cancer Bristol-Myers Squibb 530
Testing effectiveness (Phase 2)UnknownNCT03253068What this trial is testingPembrolizumab Plus Amurubicin in Patients With Refractory Small-cell Lung CancerWho this might be right forSmall Cell Lung Cancer Extensive Stage Wakayama Medical University 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT03830918What this trial is testingNiraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line ChemotherapyWho this might be right forAdvanced Malignant Solid NeoplasmExtensive Stage Lung Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more Jonsson Comprehensive Cancer Center 59
Large-scale testing (Phase 3)Study completedNCT00006349What this trial is testingDonepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung CancerWho this might be right forCognitive/Functional EffectsDeliriumDepression+2 more Alliance for Clinical Trials in Oncology 9
Testing effectiveness (Phase 2)WithdrawnNCT03402880What this trial is testingALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung CancerWho this might be right forExtensive Stage Small Cell Lung Carcinoma City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT00658580What this trial is testingRandomized Study of Cisplatin-Etoposide Versus an Etoposide Regimen Without Cisplatin in Extensive Small-Cell Lung CancerWho this might be right forSmall Cell Lung Carcinoma, Extensive Disease European Lung Cancer Working Party 361